Michelle Malkin has been one of the real warriors on the right over the past few years. A lot of conservatives SAY they oppose “cancel culture,” but Malkin really means it, and has stood up for figures like Nick Fuentes when others have denounced them. And she hasn’t been afraid to take positions that will get her trouble with conservative outlets that try to stay “respectable” in Washington or in Silicon Valley.
Michelle has a new article out: “What Every Parent Must Know About Pfizer.” And it’s worth reading because right now there’s a lot that is worth knowing about Pfizer. On Tuesday, Pfizer CEO Albert Bourla said that anybody who criticizes his vaccine is a “criminal.”
Of course, if Bourla wants to find some criminals he might consider ferreting around his own corporation. He’s some of the material from Malkin’s article.
Quote: “Twenty-five years ago, Pfizer sent a team to Nigeria during a meningitis outbreak. They conducted an “open-label” (unblinded) clinical trial involving 200 children. Half of them were given Pfizer’s new antibiotic Trovan and half of them received the gold standard treatment, ceftriaxone.”
So, we have a gold standard, cheap treatment that works well, and then we have a novel new drug Pfizer really wants to sell. Sound familiar? Anyway, Malkin continues: “Pfizer used substantially lower doses of ceftriaxone to rig the trial results in favor of Trovan. At the time of the Kano trial, Pfizer was pushing for FDA approval of their latest potential billion-dollar cash cow for pediatric use. Eleven Nigerian children died: five after receiving Pfizer’s product and six after receiving lower-than-normal doses of the older drug.”